Pan-antiviral effects of a PIKfyve inhibitor on respiratory virus infection in human nasal epithelium and mice.

Baker, Jonathan; Ombredane, Hugo; Daly, Leah; Knowles, Ian; Rapeport, Garth; Ito, Kazuhiro

Baker, Jonathan; Ombredane, Hugo; Daly, Leah; Knowles, Ian; Rapeport, Garth; Ito, Kazuhiro.

Afiliación

Baker J; National Heart and Lung Institute, Imperial College , London, United Kingdom.
Ombredane H; National Heart and Lung Institute, Imperial College , London, United Kingdom.
Daly L; National Heart and Lung Institute, Imperial College , London, United Kingdom.
Knowles I; Pharmidex , London, United Kingdom.
Rapeport G; National Heart and Lung Institute, Imperial College , London, United Kingdom.
Ito K; National Heart and Lung Institute, Imperial College , London, United Kingdom.

Antimicrob Agents Chemother ; 68(1): e0105023, 2024 Jan 10.

Article en En | MEDLINE | ID: mdl-38063402

Asunto(s)

Fiebre Hemorrágica Ebola; Gripe Humana; Humanos; Animales; Ratones; Oseltamivir; Antivirales/farmacología; Antivirales/uso terapéutico; Mucosa Nasal

Palabras clave

Apilimod; PIKfyve; air-liquid interface; coronavirus; human rhinovirus; influenza; respiratory syncytial virus

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Gripe Humana Límite: Animals / Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google